Literature DB >> 12829985

Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C.

Cristina Rigamonti1, Elisa Mottaran, Emanuela Reale, Roberta Rolla, Valentina Cipriani, Francesca Capelli, Renzo Boldorini, Matteo Vidali, Massimo Sartori, Emanuele Albano.   

Abstract

The mechanisms by which alcohol consumption worsens the evolution of chronic hepatitis C (CHC) are poorly understood. We have investigated the possible interaction between hepatitis C virus (HCV) and ethanol in promoting oxidative stress. Circulating IgG against human serum albumin (HSA) adducted with malondialdehyde (MDA-HSA), 4-hydroxynonenal (HNE-HSA), or arachidonic acid hydroperoxide (AAHP-HSA) and against oxidized cardiolipin (Ox-CL) were evaluated as markers of oxidative stress in 145 CHC patients with different alcohol consumption, 20 HCV-free heavy drinkers (HD) without liver disease, and 50 healthy controls. Anti-MDA IgG was increased in CHC patients irrespective of alcohol intake as well as in the HD group. CHC patients with moderate alcohol intake (<50 g ethanol/d), but not HD, also had significantly higher values of anti-AAHP-HSA, anti-HNE-HSA, and anti-Ox-CL IgG (P <.05) than controls. A further elevation (P <.001) of these antibodies was evident in CHC patients with heavy alcohol intake (>50 g ethanol/d). Anti-AAHP and anti-Ox-CL IgG above the 95th percentile in the controls were observed in 24% to 26% of moderate and 58% to 63% of heavy drinkers but only in 6% to 9% of the abstainers. The risk of developing oxidative stress during CHC was increased 3-fold by moderate and 13- to 24-fold by heavy alcohol consumption. Heavy drinking CHC patients had significantly more piecemeal necrosis and fibrosis than abstainers. Diffuse piecemeal necrosis was 4-fold more frequent among alcohol-consuming patients with lipid peroxidation-related antibodies than among those without these antibodies. In conclusion, even moderate alcohol consumption promotes oxidative stress in CHC patients, suggesting a role for oxidative injury in the worsening of CHC evolution by alcohol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829985     DOI: 10.1053/jhep.2003.50275

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Authors:  Li Ye; Shihong Wang; Xu Wang; Yu Zhou; Jieliang Li; Yuri Persidsky; Wenzhe Ho
Journal:  Drug Alcohol Depend       Date:  2010-06-20       Impact factor: 4.492

3.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.

Authors:  E Albano; E Mottaran; M Vidali; E Reale; S Saksena; G Occhino; A D Burt; C P Day
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis.

Authors:  Paolo Sorrentino; Luigi Terracciano; Salvatore D'Angelo; Umberto Ferbo; Alessandra Bracigliano; Luciano Tarantino; Alessandro Perrella; Oreste Perrella; Giovanni De Chiara; Luigi Panico; Noè De Stefano; Mariolina Lepore; Raffaela Vecchione
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

5.  Psychosocial correlates of alcohol use and reduction for individuals with hepatitis C.

Authors:  Adam T Perzynski; Richard McCormick; Noah J Webster; Carol E Blixen; Stephanie Kanuch; Charles L Thomas; Kevin D Mullen; Neal V Dawson
Journal:  J Stud Alcohol Drugs       Date:  2011-09       Impact factor: 2.582

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity.

Authors:  R Rolla; M Vidali; R Serino; P Pergolini; E Albano; G Bellomo
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

Review 8.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

Review 9.  Molecular mechanisms of alcoholic fatty liver.

Authors:  Vishnudutt Purohit; Bin Gao; Byoung-Joon Song
Journal:  Alcohol Clin Exp Res       Date:  2008-11-19       Impact factor: 3.455

10.  Redox mechanisms in hepatic chronic wound healing and fibrogenesis.

Authors:  Erica Novo; Maurizio Parola
Journal:  Fibrogenesis Tissue Repair       Date:  2008-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.